Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study. [electronic resource] by
- Fenk, R
- Schneider, P
- Kropff, M
- Huenerlituerkoglu, A N
- Steidl, U
- Aul, C
- Hildebrandt, B
- Haas, R
- Heyll, A
- Kobbe, G
Producer: 20050922
In:
British journal of haematology vol. 130
Availability: No items available.
|
|
13.
|
Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment. [electronic resource] by
- Kreuter, M
- Kropff, M
- Fischaleck, A
- Junker, K
- Gerss, J
- Heinecke, A
- Lindermann, M
- Reinmuth, N
- Berdel, W E
- Mesters, R M
- Thomas, M
Producer: 20090917
In:
The European respiratory journal vol. 33
Availability: No items available.
|
|
14.
|
Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma. [electronic resource] by
- Palumbo, A
- Davies, F
- Kropff, M
- Bladé, J
- Delforge, M
- Leal da Costa, F
- Garcia Sanz, R
- Schey, S
- Facon, T
- Morgan, G
- Moreau, P
Producer: 20100709
In:
Annals of hematology vol. 89
Availability: No items available.
|
|
15.
|
|
|
16.
|
Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients. [electronic resource] by
- Kröger, N
- Zabelina, T
- Klyuchnikov, E
- Kropff, M
- Pflüger, K-H
- Burchert, A
- Stübig, T
- Wolschke, C
- Ayuk, F
- Hildebrandt, Y
- Bacher, U
- Badbaran, A
- Schilling, G
- Hansen, T
- Atanackovic, D
- Zander, A R
Producer: 20140128
In:
Bone marrow transplantation vol. 48
Availability: No items available.
|
|
17.
|
Improving global integration of crop research. [electronic resource] by
- Reynolds, M P
- Braun, H J
- Cavalieri, A J
- Chapotin, S
- Davies, W J
- Ellul, P
- Feuillet, C
- Govaerts, B
- Kropff, M J
- Lucas, H
- Nelson, J
- Powell, W
- Quilligan, E
- Rosegrant, M W
- Singh, Ravi P
- Sonder, K
- Tang, H
- Visscher, S
- Wang, R
Producer: 20180110
In:
Science (New York, N.Y.) vol. 357
Availability: No items available.
|
|
18.
|
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma. [electronic resource] by
- Einsele, H
- Knop, S
- Vogel, M
- Müller, J
- Kropff, M
- Metzner, B
- Langer, C
- Sayer, H
- Jung, W
- Dürk, H A
- Salwender, H
- Wandt, H
- Bassermann, F
- Gramatzki, M
- Rösler, W
- Wolf, H-H
- Brugger, W
- Engelhardt, M
- Fischer, T
- Liebisch, P
- Straka, C
Producer: 20180620
In:
Leukemia vol. 31
Availability: No items available.
|